Regular Cannabis Users Showed Selective Alcohol Cross-Tolerance in a Small Tracking Study
A small human study found less alcohol-related tracking deterioration in regular cannabis users than in infrequent users, while reaction-time slowing did not differ between groups. The result supports a task-specific difference, not a general exemption from alcohol impairment.
Acute cannabis was not the experimental exposure
Fourteen regular users and fourteen infrequent users were matched on several characteristics, including alcohol intake. Participants received alcohol and placebo drinks. The question was whether long-term cannabis-use history modified alcohol's effects without an acute cannabis administration condition.
Tracking and reaction time gave different answers
After placebo, tracking accuracy was similar. Alcohol caused greater deterioration among infrequent users, and dizziness ratings showed a corresponding difference. Alcohol also slowed reaction times, but that slowing did not differ between groups. Similar breath alcohol levels helped distinguish the behavioral comparison from a simple difference in measured alcohol exposure.
Urine metabolites did not measure contemporaneous impairment
Only regular users screened positive for THC metabolites in urine. That finding characterized exposure history; it did not quantify current functional impairment. The computerized tracking task involved peripheral responses but was not an on-road driving trial. Group membership was also an existing use history, not randomly assigned years of cannabis exposure.
The authors suggested cross-tolerance to specific alcohol effects. The preserved reaction-time effect and small sample limit broader claims. This experiment does not establish that regular cannabis users can safely drive after alcohol or that combining alcohol and cannabis produces the same pattern.
Related: interpreting cannabis tolerance claims.
Research cited
Wright A; Terry P. Modulation of the effects of alcohol on driving-related psychomotor skills by chronic exposure to cannabis. Psychopharmacology (2002). doi:10.1007/s00213-001-0955-4. Findings discussed from the study abstract.
